Loading…
Service
Heart disease presents differently in women — assessment should too.
Overview
Women are more likely to present with atypical symptoms, more likely to have microvascular disease, and historically more likely to be under-investigated. This programme is built around those differences rather than treating them as exceptions.
Assessment covers pregnancy-related risk history, menopause transition, autoimmune conditions, and the microvascular patterns that standard angiography can miss.
Your Pathway
No surprises — this is the sequence every patient follows for this service.
A risk history covering obstetric, hormonal, and autoimmune factors often missed elsewhere.
Testing chosen for female presentation patterns, including microvascular evaluation.
Treatment that accounts for hormonal stage and other conditions you are managing.
Structured reassessment through life-stage transitions.
Questions
Symptoms are frequently atypical — fatigue, breathlessness, or jaw and back discomfort rather than classic chest pain — and standard testing is less sensitive to microvascular disease.
Yes, significantly. Pre-eclampsia, gestational diabetes, and preterm delivery are all independently associated with later cardiovascular risk, which is why we always ask.
It depends on your age, time since menopause, and cardiovascular profile. We assess it individually and coordinate with your gynaecologist.
Book a consultation and upload any prior results beforehand so your first visit starts with the full picture.